Related Experiment Videos
Anti-TNF therapy: where have we got to in 2005?
Marc Feldmann1, Fionula M Brennan, Brian M J Foxwell
1Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College, 1 Aspenlea Road, London W6 8LH, UK. m.feldmann@imperial.ac.uk
Journal of Autoimmunity
|November 2, 2005
Summary
Tumor Necrosis Factor (TNF) blockade has transformed autoimmune disease treatment, particularly rheumatoid arthritis. Further understanding enhances its therapeutic benefits, despite existing limitations, offering promising future prospects.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Background:
- Chronic autoimmune diseases pose significant therapeutic challenges.
- Tumor Necrosis Factor (TNF) has been identified as a key mediator in inflammatory pathways.
- The development of TNF-blocking therapies marked a paradigm shift in treating autoimmune conditions.
Purpose of the Study:
- To review the historical development of TNF blockade therapy in rheumatoid arthritis (RA).
- To explore the expansion of TNF blockade into other autoimmune diseases.
- To discuss how enhanced understanding of TNF blockade has improved therapeutic outcomes.
Main Methods:
- Literature review of studies on TNF blockade in autoimmune diseases.
- Analysis of clinical data demonstrating therapeutic efficacy and limitations.
- Synthesis of current knowledge and future directions in TNF-targeted therapy.
Main Results:
- TNF blockade has profoundly impacted the management of rheumatoid arthritis.
- The application of TNF blockade has successfully extended to various other autoimmune disorders.
- Increased comprehension of TNF's role has led to augmented therapeutic benefits and personalized treatment strategies.
Conclusions:
- TNF blockade represents a cornerstone therapy for numerous chronic autoimmune diseases.
- Despite limitations, ongoing research and improved understanding continue to refine TNF-targeted treatments.
- The future of TNF blockade in autoimmune disease therapy remains highly promising, with potential for further advancements.